A new method to facilitate valid and consistent grading cardiac events in childhood cancer survivors using medical records

PLoS One. 2014 Jul 9;9(7):e100432. doi: 10.1371/journal.pone.0100432. eCollection 2014.

Abstract

Background: Cardiac events (CEs) are among the most serious late effects following childhood cancer treatment. To establish accurate risk estimates for the occurrence of CEs it is essential that they are graded in a valid and consistent manner, especially for international studies. We therefore developed a data-extraction form and a set of flowcharts to grade CEs and tested the validity and consistency of this approach in a series of patients.

Methods: The Common Terminology Criteria for Adverse Events version 3.0 and 4.0 were used to define the CEs. Forty patients were randomly selected from a cohort of 72 subjects with known CEs that had been graded by a physician for an earlier study. To establish whether the new method was valid for appropriate grading, a non-physician graded the CEs by using the new method. To evaluate consistency of the grading, the same charts were graded again by two other non-physicians, one with receiving brief introduction and one with receiving extensive training on the new method. We calculated weighted Kappa statistics to quantify inter-observer agreement.

Results: The inter-observer agreement was 0.92 (95% CI 0.80-1.00) for validity, and 0.88 (0.79-0.98) and 0.99 (0.96-1.00) for consistency with the outcome assessors who had the brief introduction and the extensive training, respectively.

Conclusions: The newly developed standardized method to grade CEs using data from medical records has shown excellent validity and consistency. The study showed that the method can be correctly applied by researchers without a medical background, provided that they receive adequate training.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Cardiotoxicity / diagnosis
  • Child
  • Child, Preschool
  • Female
  • Heart Failure / chemically induced
  • Heart Failure / diagnosis*
  • Humans
  • Infant
  • Male
  • Neoplasms / therapy*
  • Severity of Illness Index
  • Surveys and Questionnaires
  • Survivors

Substances

  • Antineoplastic Agents

Grants and funding

Financial support for this study was provided in part by a: grant from PanCare Childhood and Adolescent Cancer Survivor care and Follow-up studies Consortium (EU-Grant agreement number 257505) and Swiss Cancer League (KLS-02783-02-2011). The funding agreement ensured the authors’ independence in designing the study, interpreting the data, writing, and publishing the report.